News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Emergent BioSolutions
NEWS
JOBS
IN THE PRESS
NEWS
Business
Drugmakers Like Johnson & Johnson, Emergent BioSolutions, And Mapp Biopharmaceutical Stand To Gain Ebola Contracts Worth $2 Billion
November 11, 2014
·
1 min read
Biotech Beach
The Day In Review: BioSimilar Drug Enters Trial
March 21, 2007
·
1 min read
Biotech Beach
The Day In Review: Allergan Inc. Expands Obesity Franchise
February 23, 2007
·
1 min read
Deals
IPO Watch: Emergent BioSolutions Makes Anthrax Vaccine
November 16, 2006
·
1 min read
Biotech Beach
The Week In Review: Strong Gain; Stronger Breadth
August 21, 2006
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
BioCapital
Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024
January 9, 2024
·
2 min read
BioCapital
Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted)
November 28, 2023
·
5 min read
Deals
Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q Filing
November 24, 2023
·
3 min read
Business
Emergent BioSolutions Reports Third Quarter 2023 Financial Results
November 8, 2023
·
23 min read
Business
UPDATE: Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on November 8, 2023
October 30, 2023
·
1 min read
Business
Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on November 2, 2023
October 19, 2023
·
1 min read
BioCapital
Emergent BioSolutions’ NARCAN® Nasal Spray Launches Over the Counter Making it Possible for Everyone to Help Save a Life from an Opioid Overdose Emergency
August 30, 2023
·
8 min read
Business
Emergent BioSolutions Reports Financial Results for Second Quarter 2023
August 8, 2023
·
35 min read
BioCapital
Emergent BioSolutions Announces Strategic Steps to Strengthen Core Business and Financial Position
August 8, 2023
·
5 min read
BioCapital
Emergent BioSolutions Awarded 10-Year BARDA Contract Valued at up to a Maximum of $704 Million for Advanced Development and Procurement of Ebanga™ Treatment for Ebola
July 31, 2023
·
5 min read
